Athenex, founded in 2003, is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. The Company’s mission is to become a global leader in bringing innovative cancer treatments to the market and to improve health outcomes.

The Company’s executive team brings complementary skill sets together across global pharmaceutical R&D, operations, supply chain and manufacturing, capital markets, and mergers and acquisitions.